Naoki Teno

786 total citations
52 papers, 561 citations indexed

About

Naoki Teno is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Naoki Teno has authored 52 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Naoki Teno's work include Protease and Inhibitor Mechanisms (18 papers), Chemical Synthesis and Analysis (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Naoki Teno is often cited by papers focused on Protease and Inhibitor Mechanisms (18 papers), Chemical Synthesis and Analysis (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Naoki Teno collaborates with scholars based in Japan, Switzerland and United Kingdom. Naoki Teno's co-authors include Takuya Sueda, Keigo Gohda, Keiko Wanaka, Yuko Tsuda, Yukiko Yamashita, Yoshio Okada, Ko Fujimori, Shinichi Koizumi, Hidefumi Uchiyama and Akiko Hijikata‐Okunomiya and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Naoki Teno

51 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Teno Japan 15 218 156 154 133 72 52 561
Daniel J. Burdick United States 13 353 1.6× 77 0.5× 46 0.3× 96 0.7× 63 0.9× 19 613
Richard Faint United Kingdom 13 193 0.9× 84 0.5× 175 1.1× 87 0.7× 181 2.5× 17 556
Moorthy S. S. Palanki United States 18 441 2.0× 110 0.7× 118 0.8× 297 2.2× 46 0.6× 28 818
Vincent Guerlavais United States 11 397 1.8× 214 1.4× 39 0.3× 102 0.8× 14 0.2× 22 650
Giang T. Le Australia 14 537 2.5× 108 0.7× 61 0.4× 249 1.9× 113 1.6× 18 825
Volker Badock Germany 14 687 3.2× 124 0.8× 102 0.7× 30 0.2× 72 1.0× 17 909
Chie‐Hong Wang Taiwan 14 355 1.6× 202 1.3× 202 1.3× 202 1.5× 9 0.1× 26 792
Angelo Lupo Italy 16 673 3.1× 199 1.3× 126 0.8× 27 0.2× 27 0.4× 32 880
Rongzhen Lu United States 6 540 2.5× 140 0.9× 187 1.2× 62 0.5× 24 0.3× 6 808
Yoshiyuki Nishikawa Japan 13 468 2.1× 131 0.8× 110 0.7× 141 1.1× 10 0.1× 28 745

Countries citing papers authored by Naoki Teno

Since Specialization
Citations

This map shows the geographic impact of Naoki Teno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Teno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Teno more than expected).

Fields of papers citing papers by Naoki Teno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Teno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Teno. The network helps show where Naoki Teno may publish in the future.

Co-authorship network of co-authors of Naoki Teno

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Teno. A scholar is included among the top collaborators of Naoki Teno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Teno. Naoki Teno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Teno, Naoki, Keisuke Oda, Yukiko Yamashita, et al.. (2021). Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum. ACS Medicinal Chemistry Letters. 12(3). 420–425. 15 indexed citations
3.
4.
Gohda, Keigo, Ko Fujimori, Yukiko Yamashita, et al.. (2020). N1-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR). Bioorganic & Medicinal Chemistry. 28(14). 115512–115512. 9 indexed citations
5.
6.
Teno, Naoki, et al.. (2017). Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists. Bioorganic & Medicinal Chemistry. 25(6). 1787–1794. 7 indexed citations
7.
Teno, Naoki, Keigo Gohda, Yukiko Yamashita, et al.. (2016). Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 26(9). 2259–2261. 8 indexed citations
8.
Teno, Naoki, Keigo Gohda, Keiko Wanaka, et al.. (2015). Novel type of plasmin inhibitors: Providing insight into P4 moiety and alternative scaffold to pyrrolopyrimidine. Bioorganic & Medicinal Chemistry. 23(13). 3696–3704. 8 indexed citations
9.
Teno, Naoki, Keigo Gohda, Keiko Wanaka, et al.. (2014). Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin. Bioorganic & Medicinal Chemistry. 22(7). 2339–2352. 10 indexed citations
10.
Teno, Naoki, Keigo Gohda, Keiko Wanaka, Takuya Sueda, & Yuko Tsuda. (2011). Identification of novel plasmin inhibitors possessing nitrile moiety as warhead. Bioorganic & Medicinal Chemistry Letters. 21(21). 6305–6309. 9 indexed citations
11.
Masuya, Keiichi & Naoki Teno. (2010). Small molecules for bone diseases. Expert Opinion on Therapeutic Patents. 20(4). 563–582. 4 indexed citations
12.
Ehara, Takeru, Fumiaki Yokokawa, Junichi Sakaki, et al.. (2008). Discovery of selective and nonpeptidic cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(14). 3959–3962. 14 indexed citations
13.
Tsutsumi, Ken‐ichi, et al.. (2008). Species Differences Between Human and Rat in the Substrate Specificity of Cathepsin K. The Journal of Biochemistry. 144(4). 499–506. 7 indexed citations
14.
Teno, Naoki, et al.. (2008). New chemotypes for cathepsin K inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2599–2603. 12 indexed citations
15.
Nosaka, Atsuko Y., Kenji Kanaori, Naoki Teno, et al.. (1999). Conformational Studies on the Specific Cleavage Site of Type I Collagen (α-1) Fragment (157–192) by Cathepsins K and L by Proton NMR Spectroscopy. Bioorganic & Medicinal Chemistry. 7(2). 375–379. 15 indexed citations
16.
Teno, Naoki, et al.. (1991). Development of Selective Inhibitors against Plasma Kallikrein.. Chemical and Pharmaceutical Bulletin. 39(11). 2930–2936. 6 indexed citations
17.
Teno, Naoki, et al.. (1991). Development of Active Center-Directed Inhibitors against Plasmin.. Chemical and Pharmaceutical Bulletin. 39(9). 2340–2346. 16 indexed citations
18.
19.
Hijikata‐Okunomiya, Akiko, Shosuke Okamoto, Yoshio Okada, & Naoki Teno. (1988). Structure-Activity Relationship between Arginine Derivatives and Inhibitory Activity of Horse Serum Cholinesterase. Kobe University Repository Kernel (Kobe University). 4. 39–46. 1 indexed citations
20.
Okada, Yoshio, et al.. (1988). Amino acids and peptides. XX. Inhibition of papain by succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide, a common sequence of endogenous thiol proteinase inhibitors.. Chemical and Pharmaceutical Bulletin. 36(6). 1982–1989. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel J. Burdick Breakdown of academic impact, for papers by Richard Faint Breakdown of academic impact, for papers by Moorthy S. S. Palanki Breakdown of academic impact, for papers by Vincent Guerlavais Breakdown of academic impact, for papers by Giang T. Le Breakdown of academic impact, for papers by Volker Badock Breakdown of academic impact, for papers by Chie‐Hong Wang Breakdown of academic impact, for papers by Angelo Lupo Breakdown of academic impact, for papers by Rongzhen Lu Breakdown of academic impact, for papers by Yoshiyuki Nishikawa
Rankless by CCL
2026